Elisabetta Puliga

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Gas Chromatography

Peritoneal Dialysis

Top Venues

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Elisabetta Puliga, Chiara De Bellis, Sandra Vietti Michelina, Tania Capeloa, Cristina Migliore, Claudia Orrù, Gian Luca Baiocchi, Giovanni De Manzoni, Filippo Pietrantonio, Rossella Reddavid, Uberto Fumagalli Romario, Chiara Ambrogio, Simona Corso, Silvia Giordano
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (3) (2024)
Elisabetta Puliga, Chiara De Bellis, Sandra Vietti Michelina, Tania Capeloa, Cristina Migliore, Claudia Orrù, Gian Luca Baiocchi, Giovanni De Manzoni, Filippo Pietrantonio, Rossella Reddavid, Uberto Fumagalli Romario, Chiara Ambrogio, Simona Corso, Silvia Giordano
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2024)
Elisabetta Puliga, Chiara De Bellis, Sandra Vietti Michelina, Tania Capeloa, Cristina Migliore, Claudia Orrù, Gian Luca Baiocchi, Giovanni De Manzoni, Filippo Pietrantonio, Rossella Reddavid, Uberto Fumagalli Romario, Chiara Ambrogio, Simona Corso, Silvia Giordano
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (3) (2024)
Elisabetta Puliga, Chiara De Bellis, Sandra Vietti Michelina, Tania Capeloa, Cristina Migliore, Claudia Orrù, Gian Luca Baiocchi, Giovanni De Manzoni, Filippo Pietrantonio, Rossella Reddavid, Uberto Fumagalli Romario, Chiara Ambrogio, Simona Corso, Silvia Giordano
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (3) (2024)
Elisabetta Puliga, Chiara De Bellis, Sandra Vietti Michelina, Tania Capeloa, Cristina Migliore, Claudia Orrù, Gian Luca Baiocchi, Giovanni De Manzoni, Filippo Pietrantonio, Rossella Reddavid, Uberto Fumagalli Romario, Chiara Ambrogio, Simona Corso, Silvia Giordano
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (3) (2024)
Elisabetta Puliga, Chiara De Bellis, Sandra Vietti Michelina, Tania Capeloa, Cristina Migliore, Claudia Orrù, Gian Luca Baiocchi, Giovanni De Manzoni, Filippo Pietrantonio, Rossella Reddavid, Uberto Fumagalli Romario, Chiara Ambrogio, Simona Corso, Silvia Giordano
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (3) (2024)
Elisabetta Puliga, Chiara De Bellis, Sandra Vietti Michelina, Tania Capeloa, Cristina Migliore, Claudia Orrù, Gian Luca Baiocchi, Giovanni De Manzoni, Filippo Pietrantonio, Rossella Reddavid, Uberto Fumagalli Romario, Chiara Ambrogio, Simona Corso, Silvia Giordano
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (3) (2024)
Annalisa Petrelli, Sabrina Rizzolio, Filippo Pietrantonio, Sara Erika Bellomo, Matteo Benelli, Loris De Cecco, Dario Romagnoli, Enrico Berrino, Claudia Orrù, Salvatore Ribisi, Daniel Moya-Rull, Cristina Migliore, Daniela Conticelli, Irene M Maina, Elisabetta Puliga, Violeta Serra, Benedetta Pellegrino, Alba Llop-Guevara, Antonino Musolino, Salvatore Siena, Andrea Sartore-Bianchi, Michele Prisciandaro, Federica Morano, Maria Antista, Uberto Fumagalli Romario, Giovanni De Manzoni, Maurizio Degiuli, Gian Luca Baiocchi, Marco F Amisano, Alessandro Ferrero, Caterina Marchio, Simona Corso, Silvia Giordano
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors. Cancer research 83 (10) (2023)
Annalisa Petrelli, Sabrina Rizzolio, Filippo Pietrantonio, Sara Erika Bellomo, Matteo Benelli, Loris De Cecco, Dario Romagnoli, Enrico Berrino, Claudia Orrù, Salvatore Ribisi, Daniel Moya-Rull, Cristina Migliore, Daniela Conticelli, Irene M Maina, Elisabetta Puliga, Violeta Serra, Benedetta Pellegrino, Alba Llop-Guevara, Antonino Musolino, Salvatore Siena, Andrea Sartore-Bianchi, Michele Prisciandaro, Federica Morano, Maria Antista, Uberto Fumagalli Romario, Giovanni De Manzoni, Maurizio Degiuli, Gian Luca Baiocchi, Marco F Amisano, Alessandro Ferrero, Caterina Marchio, Simona Corso, Silvia Giordano
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors. Cancer research 83 (10) (2023)
Annalisa Petrelli, Sabrina Rizzolio, Filippo Pietrantonio, Sara Erika Bellomo, Matteo Benelli, Loris De Cecco, Dario Romagnoli, Enrico Berrino, Claudia Orrù, Salvatore Ribisi, Daniel Moya-Rull, Cristina Migliore, Daniela Conticelli, Irene M Maina, Elisabetta Puliga, Violeta Serra, Benedetta Pellegrino, Alba Llop-Guevara, Antonino Musolino, Salvatore Siena, Andrea Sartore-Bianchi, Michele Prisciandaro, Federica Morano, Maria Antista, Uberto Fumagalli Romario, Giovanni De Manzoni, Maurizio Degiuli, Gian Luca Baiocchi, Marco F Amisano, Alessandro Ferrero, Caterina Marchio, Simona Corso, Silvia Giordano
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors. Cancer research (2023)